Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Protalix BioTherapeutics, Inc. announced that Dror Bashan, the Company’s President and Chief Executive Officer, will present on Wednesday, August 9, 2023 at 3:30 p.m. Eastern Daylight Time at the Canaccord Genuity 43rd Annual Growth Conference.

Scroll to Top